Sanofi & UCMS

Multiple Sclerosis: An Era of New Opportunities.

Discussing the problem of innovative treatment available for patients with multiple sclerosis at a government level.

Attracting public attention to Ukrainians diagnosed with this rare disease.
Level 1 publications
20+ mln.
30 000+
times one piece of news was read
Every year at the end of May, the International Day Against Multiple Sclerosis is marked all over the world. The reasons why this rare disease develops are still unknown. All people, even the young ones aged 18 to 34, are at risk. Although subsidies and access to innovative drugs for Ukrainians diagnosed with multiple sclerosis (MS) are increasing every year, official statistics on the diagnosis and treatment of the disease are disappointing. According to the latest independent study (IFAK Institute GmbH & Co, 2018) in Ukraine, 57 people per 100 thousand are diagnosed with MS (while in Hungary this number is 176, in the Czech Republic — 140, and in Poland — 120).
The Ukrainian Community of People with MS (UCMS) and Sanofi-Ukraine decided to hold a press conference "Multiple Sclerosis: An Era of New Opportunities. Are We Ready for It?". The conference took place on May 28th, 2021 and its aim was to draw public attention to the problems of MS treatment as well as to the problem of MS late diagnosis in the country.
Why are these issues still important and relevant for discussion? About 65% of MS patients indicated that they did not have access to effective medication (10% of required treatment in Ukraine is covered by a government program). One in three patients with multiple sclerosis notes that it took a year for a doctor to diagnose MS (13% say about 5 years). But if multiple sclerosis had been diagnosed earlier and with the suggested innovative therapy, up to 68% of patients would not have been disabled and could have been able to study and work. To compare, in Estonia (80%) and Hungary (45%) patients diagnosed with multiple sclerosis work full-time or part-time.

Besides inviting journalists to the press conference, our team faced the task to help the organizer cover the above-mentioned problems in the Ukrainian media popular among the representatives of government agencies.

As a result, representatives of such top media as "NV.UA", "24TV", "Suspilne" joined the press conference while one of the most popular Ukrainian media resources "Ukrainska Pravda" got interested in the opportunity to take an exclusive interview with Tetyana Negrych, Doctor of Medical Sciences, Professor, Head of the Neurological Department of Lviv National Medical University and Chairman of the Lviv Regional Community of Neurologists.

As a result, more than 20 publications about modern problems of MS patients appeared in mass media over the week. The interview with Tatyana Negrych published in "Ukrainska Pravda '' was read by 19 thousand unique visitors in just one day. That proves the fact of public interest in solving problems of Ukrainians with MS and the relevancy of the discussed issues of access to innovative treatment in 2021.